CapForce Inc. Stock Price

OTCPK:CFOR Community·US$247.7m Market Cap

0 Narratives written by author
0 Comments on narratives written by author
1 Fair Values set on narratives written by author

Author Program NEW Create Narrative

CFOR Share Price Performance

US$9.09

9.05 (23,029.77%)

US$9.09

9.05 (23,029.77%)

US$9.09

Tue, 21 Jul 26

Share Pricen/a

CFOR Community Narratives

There are no narratives available yet.

Create Narrative

There are no community narratives available.

Trending Discussion

No trending discussion available.

Snowflake Analysis

Proven track record with adequate balance sheet.

4 Risks

2 Rewards

View Full Analysis

CapForce Inc. Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

n/a

: 1.87
: 90.00%
: 76.74%
: 0%

View Full Analysis

About CFOR

Founded: 2001
Employees: 3
CEO: Christian-Laurent Bonte
WebsiteView website: www.opgen.com

CapForce Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company offers Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; and collaboration services, including funded software arrangements. In addition, the company offers listing sponsorship and consultancy services. CapForce Inc. was formerly known as OpGen, Inc. and changed its name to CapForce Inc. in February 2026. CapForce Inc. was incorporated in 2001 and is headquartered in Clarksburg, Maryland.